ASX200 Watch CSL Slips Again While NAB and WBC Extend Strong Uptrends

3 min read | August 29, 2025 04:54 PM AEST | By Team Kalkine Media

Highlights

  • CSL (ASX:CSL) extends post-earnings decline, remaining under trend pressure

  • NAB (ASX:NAB) and WBC (ASX:WBC) show consistent upward movement in a strong banking trend

  • Broader ASX200 scan reveals key divergence between healthcare and financial momentum

CSL (ASX:CSL), a major constituent of the Asx 200, continues to face downward pressure, deepening its post-earnings slide. The biotech heavyweight's persistent dip contrasts sharply with rising momentum among major financial names like NAB (ASX:NAB) and WBC (ASX:WBC). The divergence is attracting wider attention across sector trend analysis and technical scan data.

CSL Dips Deeper Despite Historical Value Status

CSL has seen continued downside following earlier declines, creating a prolonged trend that appears disconnected from historical price anchors. Despite its profile as a high-weight biotech on the Asx 100, current charting patterns suggest further softness. The share price trajectory lacks meaningful reversal signals, with each attempted bounce appearing short-lived.

This technical outlook contrasts with narratives often linked to valuation recovery. Instead, market activity remains concentrated in tracking persistent lower highs, with volume movements failing to indicate capitulation or turnaround behaviour.

NAB and WBC Maintain Steady Upside Trend

While CSL struggles to gain traction, NAB and WBC continue climbing in well-formed technical channels. Both banking majors have shown sustained buying interest, particularly across medium-term timeframes. These moves place NAB and WBC as leading performers within the Asx 50 and financial sub-indexes.

Price action in NAB and WBC is characterised by consistent higher highs and accumulation on upswings. These uptrends have maintained structural integrity despite broader sectoral churn, showcasing demand resilience in financial stocks even as others undergo rotation.

Broader Trend Observations Across ASX200

The current scan across the Asx 200 highlights contrasting moves across sectors. Uranium-related equities such as Deep Yellow and Boss Energy have attracted sharp upward activity, indicating a rotation into energy-linked names. Conversely, gold and healthcare stocks like Evolution Mining and Sonic Healthcare mirror CSL's drag, suggesting a broader cooling in traditionally defensive sectors.

This sectoral divergence sets a backdrop for traders evaluating upward and downward technical flows, where banking strength counters biotech and resource softness.

Technical Signals Reinforce Sentiment Rotation

ChartWatch scans further underline a momentum-based market where price trend and sentiment are dominating decision-making over fundamentals. CSL’s continued slump exemplifies the challenges facing stocks attempting to bottom without clear technical confirmation. On the other hand, NAB and WBC reflect strong adherence to trend-following principles, with volume and structure favouring further upside continuation.

As technical patterns deepen and sectoral trends extend, market attention is likely to stay fixed on top gainers and laggards within the Asx 200.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.